Zogenix, Inc. (ZGNX) was a big mover last session with shares rising nearly 17% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company, as the stock is now up over 24% in the past one-month time frame.
This drug manufacturer has seen one positive estimate revision in the last 30 days, and the Zacks Consensus Estimate has also moved higher over the same time frame. This implies more solid trading ahead for the company. So make sure to keep an eye on this stock going forward to see if yesterday’s sharp climb can turn into more strength down the road.
Zogenix currently holds a Zacks Rank #2 (Buy) while its Earnings ESP is negative.
Other Med-Drug stocks worth considering include Sucampo Pharmaceuticals, Inc. (SCMP), Jazz Pharmaceuticals Public Limited Company (JAZZ) and Questcor Pharmaceuticals, Inc. (QCOR). While Sucampo sports a Zacks Rank #1 (Strong Buy), Jazz Pharmaceuticals and Questcor carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment